Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 15, 2014 - Issue 6
Submit an article Journal homepage
352
Views
12
CrossRef citations to date
0
Altmetric
Reviews

Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatments

Stamatis-Nick C LiossisAssociate Professor of Medicine/Rheumatology, University of Patras Medical School, Patras University Hospital, Division of Rheumatology, Department of Internal Medicine, GR 26504, Patras, Greece+30 2613 603 693; +30 2610 993 982; [email protected];Patras University Hospital, Department of Rheumatology, Patras 26504, Greece
, MD &
Konstantinos MelissaropoulosPatras University Hospital, Department of Rheumatology, Patras 26504, Greece
Pages 833-840 | Published online: 04 Mar 2014

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Alessia Leone, Savino Sciascia, Ameer Kamal & Munther Khamashta. (2015) Biologicals for the treatment of systemic lupus erythematosus: current status and emerging therapies. Expert Review of Clinical Immunology 11:1, pages 109-116.
Read now

Articles from other publishers (11)

Yi Zhang, FengQi Zhang, YiNi Gao, MeiJiao Wang, Yan Gao, HaiChang Li, Jing Sun, ChengPing Wen & ZhiJun Xie. (2022) Triptolide in the treatment of systemic lupus erythematosus - regulatory effects on miR-146a in B cell TLR7 signaling pathway in mice. Frontiers in Pharmacology 13.
Crossref
Yosuke Kunishita, Ryusuke Yoshimi, Reikou Kamiyama, Daiga Kishimoto, Takaaki Komiya, Natsuki Sakurai, Yumiko Sugiyama, Kaoru Takase-Minegishi, Yohei Kirino, Shouhei Nagaoka & Hideaki Nakajima. (2021) Anti-TRIM21 antibody is associated with aberrant B-cell function and type I interferon production in systemic lupus erythematosus. Lupus 30:13, pages 2054-2065.
Crossref
Ina Georg, Alejandro Díaz-Barreiro, Maria Morell, Angel L. Pey & Marta E. Alarcón-Riquelme. (2019) BANK1 interacts with TRAF6 and MyD88 in innate immune signaling in B cells. Cellular & Molecular Immunology 17:9, pages 954-965.
Crossref
Yosuke Kunishita, Ryusuke Yoshimi, Reikou Kamiyama, Daiga Kishimoto, Koji Yoshida, Eijin Hashimoto, Takaaki Komiya, Natsuki Sakurai, Yumiko Sugiyama, Yohei Kirino, Keiko Ozato & Hideaki Nakajima. (2020) TRIM21 Dysfunction Enhances Aberrant B-Cell Differentiation in Autoimmune Pathogenesis. Frontiers in Immunology 11.
Crossref
Chenqiong Wang, Bingxia Ming, Xuefen Wu, Tong Wu, Shaozhe Cai, Peng Hu, Jungen Tang, Zheng Tan, Chaohong Liu, Jixin Zhong, Fang Zheng & Lingli Dong. (2019) Sphingomyelin synthase 1 enhances BCR signaling to promote lupus-like autoimmune response. EBioMedicine 45, pages 578-587.
Crossref
Daniel Ramsköld, Ioannis Parodis, Tadepally Lakshmikanth, Natalie Sippl, Mohsen Khademi, Yang Chen, Agneta Zickert, Jaromír Mikeš, Adnane Achour, Khaled Amara, Fredrik Piehl, Petter Brodin, Iva Gunnarsson & Vivianne Malmström. (2019) B cell alterations during BAFF inhibition with belimumab in SLE. EBioMedicine 40, pages 517-527.
Crossref
Vaishali R. Moulton, Abel Suarez-Fueyo, Esra Meidan, Hao Li, Masayuki Mizui & George C. Tsokos. (2017) Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective. Trends in Molecular Medicine 23:7, pages 615-635.
Crossref
Caroline Gordon, David Wofsy, Stephen Wax, Yong Li, Claudia Pena Rossi & David Isenberg. (2016) Post Hoc Analysis of the Phase II/III APRIL‐SLE Study: Association Between Response to Atacicept and Serum Biomarkers Including BLyS and APRIL. Arthritis & Rheumatology 69:1, pages 122-130.
Crossref
William Hoffman, Fadi G. Lakkis & Geetha Chalasani. (2016) B Cells, Antibodies, and More. Clinical Journal of the American Society of Nephrology 11:1, pages 137-154.
Crossref
Terry King-Wing Ma, Stephen P. McAdoo & Frederick Wai-Keung Tam. (2016) Spleen Tyrosine Kinase: A Crucial Player and Potential Therapeutic Target in Renal Disease. Nephron 133:4, pages 261-269.
Crossref
LiDan Zhao, YanXia Ye & Xuan Zhang. (2015) B cells biology in systemic lupus erythematosus—from bench to bedside. Science China Life Sciences 58:11, pages 1111-1125.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.